-
PDF
- Split View
-
Views
-
Cite
Cite
Asalya Abduvakhitova, #326 Features of intrarenal hemodynamics in patients with chronic glomerulonephritis on the background of taking anticoagulants, Nephrology Dialysis Transplantation, Volume 39, Issue Supplement_1, May 2024, gfae069–0383–326, https://doi.org/10.1093/ndt/gfae069.383
- Share Icon Share
Abstract
Chronic glomerulonephritis (CGN)-glomerular, autoimmune kidney disease, where baseline therapy is clinically proven to be successful. The study evaluates hemodynamic disorders of renal blood flow in patients with CGN on the background of baseline treatment with the inclusion of rivaroxaban.
We researched108 patients CGN against the background of 3-month basic therapy with the inclusion of rivaroxaban (group AC+, 55 patients) and without anticoagulant (group AC-, 53 patients). Initial and after 3 months evaluation in the mode of color Doppler mapping and pulse-wave doppler.
In the course of 3-month therapy, the performance of dopplerography of renal arteries in patients with CGN did not change reliably. But there was a credible and clinically significant increase in the systolic blood flow rate at the level of the Interregional Artery (IA), both compared to the baseline data and towards the end of hospitalization (by 9.27 2.58% p < 0.001 the validity of the difference with the raw data, by 8.60 2.53%, p < 0.01 with the 10th day of therapy), remaining reliably lower than in control group (p < 0.001). The speed at the arc artery (АА) also increased slightly (by 2.46 1.03%, p < 0.05 reliability of the difference with the original data and the end of hospitalization), but although statistical reliability was achieved, the dynamics was clinically insignificant and was less than 2.5%. The resistivity index (RI) at both IA and AA levels did not change reliably.
In CGN patients, intrarenal hemodynamics change with decreased blood flow rates in IA and AA. In the future, against the background of 3-month basic HGH therapy, there was some improvement in blood flow at the IA level but not AA, but no qualitative changes in intrarenal hemodynamics were achieved. The supplementation of long-term anticoagulation therapy with rivaroxaban has increased the effect of therapy on hemodynamic rates, resulting in some improvement in blood flow at both IA and AA levels, but no qualitative improvement has been achieved, possible due to pronounced structural remodeling of kidney vessels in patients with CGN.
Comments